Sat.Aug 17, 2024

article thumbnail

STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy

STAT

It’s been a hard week for the psychedelics pioneer Rick Doblin.  First, the Food and Drug Administration declined to approve the MDMA-assisted therapy for post-traumatic stress disorder developed by Lykos Therapeutics, a company that he founded. The next day, the journal Psychopharmacology retracted three studies on the treatment, in which many authors were associated with Lykos or the nonprofit Doblin founded, the Multidisciplinary Association for Psychedelic Studies (MAPS).

FDA 145
article thumbnail

Food As Medicine Can Change Patient Lives, But Establishing Models, Payment Pathways Is Critical

Pharmacy Times

New payment frameworks are emerging, but pharmacists need to be central to the ongoing food as medicine movement.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: First Opinion readers on Noah Lyles and Covid-19, the dearth of geriatricians, PBMs, and more

STAT

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.

FDA 110
article thumbnail

Now Trending: Breast Cancer in Men, Fruit and Vegetables for Hypertension

Drug Topics

Check out this recap of articles published on our sister sites during the past week.

98
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Expert: Community Pharmacists Key to Optimizing Care for Patients

Pharmacy Times

Rina Shah discusses the importance of community pharmacy and how pharmacists can optimize care for patients.

article thumbnail

Small Doses: August 12 to August 16

Drug Topics

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

98

More Trending

article thumbnail

Partnerships Key to Making Sustainable Pharmacy Care Models Work

Drug Topics

Sustainable pharmacy partnerships require addressing financial, technology, and customer needs.

94
article thumbnail

How much is Zenpep without insurance?

The Checkup by Singlecare

Zenpep (pancrelipase) is a prescription medication that contains a combination of digestive enzymes. It’s approved for people with exocrine pancreatic insufficiency (EPI)–a digestive disorder that occurs when the pancreas does not make enough enzymes (proteins). This can be caused by conditions such as cystic fibrosis. Pancreatic enzymes help break down–or digest–food so nutrients from food can be absorbed by the body.

article thumbnail

Episode 582: Reducing the risk associated with risk calculators

Therapeutics Education Collaboration

In episode 582, Mike and James go over the issues associated with using CVD risk calculators. We talk about where the numbers come from, what they mean, what their limitations are, how to think about them and how to use them. So have a listen as it may decrease your risk but it will definitely increase your understanding. Show notes 1) PEER Simplified Cardiovascular Decision Aid [link] 2) Incorporation of Shared Decision-Making in International Cardiovascular Guidelines, 2012-2022 JAMA Network O

article thumbnail

Clonazepam for dogs: Dosage and safety

The Checkup by Singlecare

Clonazepam is a prescription benzodiazepine, a class of drugs that slows down the nervous system. Also sold as brand-name Klonopin , veterinarians use clonazepam in dogs as an add-on treatment for seizures and use it alone to reduce anxiety in the dog. It may have other uses, such as a muscle relaxant or a sleep aid. Clonazepam is safe for dogs when given as recommended, but long-term therapy can cause dependence, tolerance, and withdrawal when it’s stopped.

Dosage 52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Failure to deal with mpox outbreak ‘is risk not just to Africa but whole world’

The Guardian - Pharmaceutical Industry

Health leaders warn that global response to virus is test case for equity and preparation for future pandemics A failure to show solidarity with African countries at the heart of the mpox outbreak will put the world at risk and harm preparations for future pandemics, health leaders have said. The World Health Organization on Wednesday declared an international public health emergency in the face of rising cases that are spreading beyond the Democratic Republic of the Congo (DRC), where the virus

111
111